Skip to main content
Livermore
Livermore
ZHEN

Dodge & Cox

SEC CIK
0000200217
Latest filing
Aug 13, 2026

GSK holding history

GSK plc in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
48,197,514
Value
$2.53B
% of portfolio
1.3%
Quarters held
22
Since Q1 2021
Holdings of GSK by Dodge & Cox, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202648,197,514$2.53B1.3%−10,465,460−17.8%ReducedHolders
Q1 202658,662,974$3.24B1.8%−9,854,995−14.4%ReducedHolders
Q4 202568,517,969$3.36B1.8%−9,885,765−12.6%ReducedHolders
Q3 202578,403,734$3.38B1.8%−354,135−0.4%ReducedHolders
Q2 202578,757,869$3.02B1.7%+106,036+0.1%AddedHolders
Q1 202578,651,833$3.05B1.7%+10,210,921+14.9%AddedHolders
Q4 202468,440,912$2.31B1.3%+353,749+0.5%AddedHolders
Q3 202468,087,163$2.78B1.6%−249,975−0.4%ReducedHolders
Q2 202468,337,138$2.63B1.6%−525,170−0.8%ReducedHolders
Q1 202468,862,308$2.95B1.7%−164,485−0.2%ReducedHolders
Q4 202369,026,793$2.56B1.6%−254,390−0.4%ReducedHolders
Q3 202369,281,183$2.51B1.7%−330,085−0.5%ReducedHolders
Q2 202369,611,268$2.48B1.7%−95,800−0.1%ReducedHolders
Q1 202369,707,068$2.48B1.7%+4,774,116+7.4%AddedHolders
Q4 202264,932,952$2.28B1.6%+6,348,963+10.8%AddedHolders
Q3 202258,583,989$1.72B1.3%−15,658,733−21.1%ReducedHolders
Q2 202274,242,722$3.23B2.2%−11,507,899−13.4%ReducedHolders
Q1 202285,750,621$3.74B2.3%−2,768,823−3.1%ReducedHolders
Q4 202188,519,444$3.90B2.4%+501,530+0.6%AddedHolders
Q3 202188,017,914$3.36B2.2%−191,275−0.2%ReducedHolders
Q2 202188,209,189$3.51B2.3%+261,944+0.3%AddedHolders
Q1 202187,947,245$3.14B2.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.